View:
Download DOC
Download PDF
Download XLS

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO §240.13d-2

 

(Amendment No. ) *

 

 

Zura Bio Limited

(Name of Issuer)

 

Class A Ordinary Shares, $0.0001 par value

(Title of Class of Securities)

 

(CUSIP Number) G9TY5A101

 

March 20, 2023

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1 (b)

 

¨ Rule 13d-1 (c)

 

x Rule 13d-1 (d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

(Continued on following page(s))

Page 1 of 5 Pages

 

 

 

 

 

 

CUSIP No. G9TY5A101   13G   Page 2 of 5 Pages

             
  1    

  NAME OF REPORTING PERSON

 

  Ewon Comfortech Co., Ltd.

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ¨        (b)  ¨

 

  3    

  SEC USE ONLY

 

  4    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Republic of Korea

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     5    

  SOLE VOTING POWER

 

  3,653,466

  6    

  SHARED VOTING POWER

 

 0

  7    

  SOLE DISPOSITIVE POWER

 

  3,653,466

  8    

  SHARED DISPOSITIVE POWER

 

  0

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,653,466

10    

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

  ¨

11    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  12.5%

12    

  TYPE OF REPORTING PERSON*

 

  OO

 

(1)Based on 29,205,614 Class A Ordinary Shares deemed to be outstanding, consisting of (i) 27,552,148 Class A Ordinary Shares currently issued and outstanding as set forth in the Issuer’s Current Report on Form 8-K dated March 20, 2023, and filed with the SEC on March 24, 2023, and (ii)  1,653,466 Class A Ordinary Shares underlying the private placement warrants.

 

 

 

 

CUSIP No. G9TY5A101   13G   Page 3 of 5 Pages

 

Item 1.

 

  (a)

Name of Issuer:

 

Zura Bio Limited (f/k/a JATT Acquisition Corp)

 

  (b)

Address of Issuer’s Principal Executive Offices:

 

4225 Executive Square, Suite 600, La Jolla, CA 92037

 

Item 2.

 

  (a) Name of Person Filing:
     
    Ewon Comfortech Co., Ltd.

 

(b)Address of Principal Business Office or if none, Residence:
   
  8 Cheomdan 1-ro Jeongeup, Jeonbuk, 56212 Republic of Korea

 

  (c) Citizenship: Republic of Korea

 

  (d) Title of Class of Securities: Class A Ordinary Shares, $0.0001 par value

 

  (e) CUSIP Number: G9TY5A101

 

Item 3.Not Applicable

 

Item 4.Ownership.

 

    The information requested in this item is incorporated herein by reference to rows 5 through 11 of the cover page to this Schedule 13G.

 

 

 

 

CUSIP No. G9TY5A101   13G   Page 4 of 5 Pages

 

Item 5. Ownership of Five Percent or Less of a Class: Not Applicable

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not Applicable

 

Item 7. Identification and Classification of Subsidiary Which Acquired the Securities: Not Applicable

 

Item 8. Identification and Classification of Members of the Group: Not Applicable

 

Item 9. Notice of Dissolution of Group: Not Applicable

 

Item 10.Certifications:

 

 By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

 

 

 

CUSIP No. G9TY5A101   13G   Page 5 of 5 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

April 12, 2023

 

  EWON COMFORTECH CO., LTD.
     
  By:

/s/ Kyung-hoon Lee

  Name: Kyung-hoon Lee
  Title: President